What is Cellectar Biosciences Inc (CLRB) stock price today?

Cellectar Biosciences Inc (CLRB) currently trades at $2.56 per share. The stock has a market capitalization of $11.70M and a P/E ratio of —x.

Is CLRB stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Cellectar Biosciences Inc has a Smart Value Score of 23/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

CLRB

Cellectar Biosciences Inc

NASDAQ: CLRB · HEALTHCARE · BIOTECHNOLOGY

$2.56

-0.02% today

Updated 2026-04-29

Market cap

$11.70M

P/E ratio

—

P/S ratio

348.47x

EPS (TTM)

$-8.35

Dividend yield

—

52W range

$2 – $21

Volume

0.0M

Market cap

$11.70M

P/E ratio

—

P/S ratio

348.47x

EPS (TTM)

$-8.35

Dividend yield

—

52W range

$2 – $21

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$12.00

+368.84%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-4.35M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-28.60M	$-42.77M	$-44.58M	$-21.79M	$-5.30M
EPS	—	—	—	—	$-8.35
Free cash flow	$-25.45M	$-33.24M	$-47.69M	$-23.12M	$-4.35M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CLRB	$11.70M	23	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Cellectar Biosciences Inc trades at $2.56. Our Smart Value Score of 23/100 indicates the stock is weak.

Frequently asked questions

What is Cellectar Biosciences Inc's stock price?

Cellectar Biosciences Inc (CLRB) trades at $2.56.

Is Cellectar Biosciences Inc overvalued?

Smart Value Score 23/100 (Grade F, Strong Sell).

What is the price target of Cellectar Biosciences Inc (CLRB)?

The analyst target price is $12.00, representing +368.8% upside from the current price of $2.56.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio348.47x

ROE-170.30%

Beta0.40

50D MA$2.99

200D MA$3.85

Shares out0.00B

Float0.00B

Short ratio—

Avg volume0.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

CLRB vs LLY →CLRB vs JNJ →CLRB vs ABBV →Stock screener →